Login / Signup

A Phase-IV Non-interventional Study to Assess Virological Effectiveness, Safety, and Tolerability of DTG-based Antiretroviral Therapy in HIV-1 Infected Indian Persons Living with HIV.

Kuldeep K AshtaSumit AroraRajesh KhannaNishant RamanAnirudh AnilkumarCharu Mohan
Published in: Current HIV research (2024)
Our results from a large Indian cohort indicate a favourable virological and metabolic response, with good tolerance of DTG-based ART at 24 weeks.
Keyphrases
  • antiretroviral therapy
  • hiv infected
  • hiv infected patients
  • human immunodeficiency virus
  • hiv positive
  • hiv aids
  • systematic review
  • open label
  • clinical trial
  • hepatitis c virus
  • double blind
  • south africa